Clinical Trial Update: Safety Study of S-CKD602 in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 safety study of S-CKD602 in patients with advanced malignancies has been completed. The study was sponsored by the University of Pittsburgh.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• S-CKD602

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 1 | Status: COMPLETED